Form 25-NSE Kezar Life Sciences, Filed by: Nasdaq Stock Market LLC
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schouw & Co. share buy-back programme, week 25 2026
- CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors
- Mkango Resources Limited Announces HyProMag USA Advances Texas Hub & Magnet Platform
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
